Charles Schwab’s Lexicon Pharmaceuticals LXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$835K Sell
883,227
-267,544
-23% -$253K ﹤0.01% 2956
2025
Q1
$530K Sell
1,150,771
-40,320
-3% -$18.6K ﹤0.01% 3065
2024
Q4
$880K Sell
1,191,091
-226,204
-16% -$167K ﹤0.01% 2958
2024
Q3
$2.23M Buy
1,417,295
+58,147
+4% +$91.3K ﹤0.01% 2678
2024
Q2
$2.28M Buy
1,359,148
+478,025
+54% +$803K ﹤0.01% 2667
2024
Q1
$2.11M Buy
881,123
+16,948
+2% +$40.7K ﹤0.01% 2575
2023
Q4
$1.32M Buy
864,175
+12,254
+1% +$18.7K ﹤0.01% 2746
2023
Q3
$929K Buy
851,921
+139,546
+20% +$152K ﹤0.01% 2824
2023
Q2
$1.63M Buy
712,375
+23,764
+3% +$54.4K ﹤0.01% 2612
2023
Q1
$1.67M Sell
688,611
-7,329
-1% -$17.8K ﹤0.01% 2571
2022
Q4
$1.33M Buy
695,940
+33,462
+5% +$63.9K ﹤0.01% 2684
2022
Q3
$1.59M Buy
662,478
+227,914
+52% +$547K ﹤0.01% 2646
2022
Q2
$809K Sell
434,564
-66,564
-13% -$124K ﹤0.01% 2874
2022
Q1
$1.05M Buy
501,128
+12,710
+3% +$26.6K ﹤0.01% 2830
2021
Q4
$1.93M Buy
488,418
+12,624
+3% +$49.8K ﹤0.01% 2714
2021
Q3
$2.29M Buy
475,794
+6,090
+1% +$29.3K ﹤0.01% 2666
2021
Q2
$2.16M Buy
469,704
+46,478
+11% +$213K ﹤0.01% 2693
2021
Q1
$2.49M Buy
423,226
+89,440
+27% +$525K ﹤0.01% 2601
2020
Q4
$1.14M Buy
333,786
+38,657
+13% +$132K ﹤0.01% 2730
2020
Q3
$425K Buy
295,129
+11,235
+4% +$16.2K ﹤0.01% 2918
2020
Q2
$567K Buy
283,894
+17,201
+6% +$34.4K ﹤0.01% 2780
2020
Q1
$521K Buy
266,693
+3,843
+1% +$7.51K ﹤0.01% 2700
2019
Q4
$1.09M Buy
262,850
+31,439
+14% +$130K ﹤0.01% 2566
2019
Q3
$697K Sell
231,411
-37,503
-14% -$113K ﹤0.01% 2673
2019
Q2
$1.69M Buy
268,914
+3,684
+1% +$23.2K ﹤0.01% 2423
2019
Q1
$1.48M Buy
265,230
+5,729
+2% +$31.9K ﹤0.01% 2449
2018
Q4
$1.72M Sell
259,501
-6,744
-3% -$44.8K ﹤0.01% 2384
2018
Q3
$2.84M Buy
266,245
+25,184
+10% +$269K ﹤0.01% 2312
2018
Q2
$2.89M Buy
241,061
+14,426
+6% +$173K ﹤0.01% 2254
2018
Q1
$1.94M Buy
226,635
+7,078
+3% +$60.7K ﹤0.01% 2344
2017
Q4
$2.17M Buy
219,557
+15,428
+8% +$152K ﹤0.01% 2277
2017
Q3
$2.51M Buy
204,129
+10,811
+6% +$133K ﹤0.01% 2211
2017
Q2
$3.18M Buy
193,318
+1,633
+0.9% +$26.9K ﹤0.01% 2040
2017
Q1
$2.75M Sell
191,685
-122,226
-39% -$1.75M ﹤0.01% 2068
2016
Q4
$4.34M Sell
313,911
-1,234
-0.4% -$17.1K ﹤0.01% 1820
2016
Q3
$5.7M Buy
315,145
+9,942
+3% +$180K 0.01% 1557
2016
Q2
$4.38M Buy
305,203
+152,735
+100% +$2.19M 0.01% 1649
2016
Q1
$1.82M Buy
152,468
+3,375
+2% +$40.3K ﹤0.01% 2096
2015
Q4
$1.99M Buy
149,093
+4,338
+3% +$57.8K ﹤0.01% 2083
2015
Q3
$1.56M Buy
144,755
+13,305
+10% +$143K ﹤0.01% 2204
2015
Q2
$1.06M Buy
131,450
+3,793
+3% +$30.6K ﹤0.01% 2392
2015
Q1
$844K Buy
127,657
+6,219
+5% +$41.1K ﹤0.01% 2441
2014
Q4
$774K Buy
121,438
+36,345
+43% +$232K ﹤0.01% 2458
2014
Q3
$840K Sell
85,093
-8,681
-9% -$85.7K ﹤0.01% 2380
2014
Q2
$1.06M Sell
93,774
-8,226
-8% -$92.7K ﹤0.01% 2286
2014
Q1
$1.24M Buy
102,000
+2,701
+3% +$32.7K ﹤0.01% 2176
2013
Q4
$1.25M Buy
99,299
+12,009
+14% +$151K ﹤0.01% 2162
2013
Q3
$1.77M Sell
87,290
-33,819
-28% -$684K ﹤0.01% 1921
2013
Q2
$1.94M Buy
+121,109
New +$1.94M ﹤0.01% 1774